DUBLIN--(BUSINESS WIRE)--The "Retinitis Pigmentosa (Retinitis) - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Retinitis Pigmentosa (Retinitis) development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline Products covered across the following Developmental Stages:
- Clinical
- Non-clinical
- Inactive: Discontinued and/or Dormant
Scope
- The report provides a snapshot of the pipeline development for Retinitis Pigmentosa (Retinitis)
- The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Retinitis Pigmentosa (Retinitis)
- The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Retinitis Pigmentosa (Retinitis)
- The report also covers the dormant and discontinued pipeline projects related to Retinitis Pigmentosa (Retinitis)
- Acucela Inc.
- Allergan PLC
- Amarantus Bioscience Holdings Inc.
- Amgen Inc.
- Applied Genetic Technologies Corp.
- Asklepios BioPharmaceutical Inc.
- Astellas Pharma Inc.
- Caladrius Biosciences Inc.
- Dompe Farmaceutici SpA
- GenSight Biologics SA
- Grupo Ferrer Internacional SA
- ID Pharma Co. Ltd.
Key Topics Covered
1. Report Introduction
2. Retinitis Pigmentosa (Retinitis) Overview
3. Pipeline Therapeutics
- An Overview of Pipeline Products for Retinitis Pigmentosa (Retinitis)
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name: Company Name
- Product Description
- Research and Development
- Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name:
Company Name
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name: Company Name
- Product Description
- Research and Development
- Product Development Activities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/nzx4nd/retinitis?w=4
